Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models

被引:3
|
作者
De Pablo-Moreno, Juan A. [1 ]
Liras, Antonio [1 ]
Revuelta, Luis [2 ]
机构
[1] Univ Complutense Madrid, Sch Biol, Dept Genet Physiol & Microbiol, Madrid, Spain
[2] Univ Complutense Madrid, Sch Vet Med, Dept Physiol, Madrid, Spain
关键词
factor V; prothrombin time; activated partial thromboplastin time; mouse; measurement standardization; transfusion; pathological models; factor V deficiency; HEMOPHILIA-A; PLASMA; TRANSFUSION; HEMORRHAGE; EVOLUTION; SELECTION;
D O I
10.3389/fvets.2022.846216
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Factor V together with activated factor X forms the prothrombinase complex, which transforms prothrombin into thrombin. The Mus musculus species is characterized by very high levels of this factor and short clotting times, which hinders accurate measurements. For that reason, a detailed characterization of such parameters is indispensable. A method was designed as part of this study to provide an accurate determination and standardization of factor V levels, prothrombin time and activated partial thromboplastin time in Mus musculus. Those parameters were evaluated in a sample of 66 healthy animals using a semi-automated coagulometer and human diagnostic reagents in an attempt to determine the most appropriate time of day for the extractions. A mouse-based protocol was designed, capable of making corrections to the samples at dilutions of 1:100 for factor V and at of 1:3 for prothrombin time. The goal was to smoothen the calibration curves, which often present with steep slopes and narrow measurement ranges between one calibration point and another. It was found that the most stable period for blood sample extraction was that comprised between the first 6 h of light. No clinical differences were observed between the sexes and reference intervals were established for factor V (95.80% +/- 18.14; 25.21 s +/- 1.34), prothrombin time (104.31% +/- 14.52; 16.85 s +/- 1.32) and activated partial thromboplastin time (32.86 s +/- 3.01). The results obtained are applicable to human or veterinary biomedical research, to transfusional medicine or to pathological models for diseases such as factor V deficiency.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Isolated prolonged activated partial thromboplastin time in an asymptomatic patient: Fletcher factor deficiency
    Acar, Kadir
    Yagci, Munci
    Sucak, Gulsan Turkoz
    Haznedar, Rauf
    THROMBOSIS RESEARCH, 2006, 118 (06) : 765 - 766
  • [22] Fatal dural sinus thrombosis associated with heterozygous factor V Leiden and a short activated partial thromboplastin time
    Stephan, CL
    SantaCruz, K
    May, C
    Wilkinson, SB
    Cunningham, MT
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2003, 127 (10) : 1359 - 1361
  • [23] EVALUATION OF ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTS IN DETECTION OF BLOOD-COAGULATION FACTOR DEFICIENCIES
    COMPTON, JL
    RODMAN, NF
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 1033 - 1033
  • [24] Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time
    Park, Kyoung-Jin
    Kwon, Eui-Hoon
    Ma, Youngeun
    Park, In-Ae
    Kim, Seon-Woo
    Kim, Sun-Hee
    Kim, Hee-Jin
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (01) : 35 - 38
  • [25] CORRELATION OF ANTI-FACTOR XA ACTIVITY VALUE, PROTHROMBIN TIME, AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PATIENTS TREATED WITH FACTOR XA INHIBITORS
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2109 - 2109
  • [26] Distribution of Anti-Factor Xa Activity Value, Prothrombin Time, and Activated Partial Thromboplastin Time in Patients Treated With Factor Xa Inhibitors
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    CIRCULATION, 2022, 146
  • [27] Establishment of reference values for prothrombin time, activated partial thromboplastin time and fibrinogen in adults in Burkina Faso
    Nebie, Koumpingnin
    Sawadogo, Salam
    Traore, Catherine
    Koulidiati, Jerome
    Kima, Donatien
    Ouedraogo, Florence Alida Wendyam
    Minoungou, Myriam Wendkuni Nikiema
    Sawadogo, Salifo
    Toure, Awa Oumar
    Kafando, Eleonore
    ANNALES DE BIOLOGIE CLINIQUE, 2023, 81 (05) : 483 - 489
  • [28] Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs
    Tseng, LW
    Hughes, D
    Giger, U
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2001, 62 (09) : 1455 - 1460
  • [29] Prolonged activated partial thromboplastin time secondary to factor XII deficiency in two surgical patients
    Moiz, Bushra
    Sadiq, Muhammed Wahhaab
    Javed, Muhammad Abdullah
    Jafry, Baqir Hasan
    Anees, Muhammad
    OXFORD MEDICAL CASE REPORTS, 2021, (03): : 76 - 78
  • [30] Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
    Bachler, Mirjam
    Niederwanger, Christian
    Hell, Tobias
    Hoefer, Judith
    Gerstmeyr, Dominic
    Schenk, Bettina
    Treml, Benedikt
    Fries, Dietmar
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (03) : 466 - 474